Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Medicine » Cardiovascular Disorders » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Fetal Alcohol Syndrome: Recognition, Differential Diagnosis and Long-Term Effects
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
01.Cardiomyopathies: Causes, Effects and Treatment
02.Progress in Cardiac Arrhythmia Research
03.Cardiovascular Diseases and Liver Transplantation
04.Cholesterol in Atherosclerosis and Coronary Heart Disease
05.Heart Disease in Women
06.Advances in Cardiovascular Research, Volume 1
07.Heart Disease in Men
08.Molecular Mechanisms of Tobacco-Induced Diseases
09.Congenital Heart Defects: Etiology, Diagnosis and Treatment
10.Coronary Artery Disease, Cardiac Arrest and Bypass Surgery: Risk Factors, Health Effects and Outcomes
Notifications more
NotificationsNotify me of updates to Atherosclerosis: Understanding Pathogenesis and Challenge for Treatment
Tell A Friend
Tell someone you know about this product.
Atherosclerosis: Understanding Pathogenesis and Challenge for Treatment
Retail Price: $49.00
10% Online Discount
You Pay:

Authors: Slavica Mitrovska , Silvana Jovanova Inge Matthiesen and Christian Libermans (Military Hospital, Department of Cardiology, Skopje, Macedonia) 
Book Description:
Atherosclerosis is a chronic inflammatory disease that affects medium and large-sized arteries. It begins after birth and the progression depends on several factors – traditional triad: hypertension, hyperlipidemia and diabetes mellitus, then age, sex, smoking and sedentary life-style. At the beginning atherosclerosis is asymptomatic and we cannot estimate appropriately its frequency, but its complications – coronary artery diseases, cerebrovascular diseases, peripheral arterial diseases, which occur late, are responsible for more than half of the yearly mortality in the world. Unfortunately, sudden cardiac death may be the first clinical manifestation.

The incipient event is endothelial dysfunction, as a result of injury, caused by high level of cholesterol [especially w-density-lipoprotein LDL], hyperglycemia, hypertension, smoking, infectious agents, and toxins. Endothelial cells overexpress adhesion molecules – vascular cell adhesion molecule–1 [VCAM-1] and increases recruitment of inflammatory cells– monocytes [Mo], T-cells and subsequent release of monocyte chemo–attractant protein–1 [MCP-1] that results in additional leucocytes recruitment. Injured endothelium allows migration of inflammatory cells that release cytokines and lipids into the intima. That leads to cytokine-mediated progression of atherosclerosis and oxidation of LDL. Macrophages [MP] take up oxi-LDL and form foam-cell. They have metabolic activity and produce cytokines, proliferation of smooth muscle cells and formulate athero-fibrose plaque.

Atherosclerotic plaque is composed of superficial layer – fibrose cap and lipid core, that consists of foam cells, extracellular lipid and necrotic cellular debris. It progresses as a result of accumulation of lipid and proliferation of smooth muscle cells and results in luminal narrowing of the arteries which leads to compromised blood and oxygen supply to the tissues. The gradually growing atherosclerotic plaques have thick fibrose cap and are stable. They cause symptoms of stable angina. Rapidly growing plaques cause unstable coronary artery disease. These plaques are mainly composed of lipids and have tiny fibrose cap that is prone to fissuring or rupture. Intraplaque hemorrhage from microvessels in plaque initiate platelet adhesion and activation of coagulation cascade that leads to platelet thrombus formation, i.e. promote thrombogenesis.

Knowledge of the pathogenesis of the atherothrombosis modifies the diagnostic and therapeutic approach.

Conclusion: Attention should be focused on the management of three points:

1. Endothelial dysfunction [correction of modified risk factors: hypertension, hyperlipidemia, diabetes mellitus, life-style-smoking, physical activity and food],
2. Atherosclerosis [modification of the inflammatory cascade, i.e. elimination of inflammatory pathways and inhibition of oxidation of LDL],
3. Thrombogenesis [inhibition of platelet adhesion, activation and aggregation].

We’ve partnered with Copyright Clearance Center to make it easy for you to request permissions to reuse Nova content.
For more information, click here or click the "Get Permission" button below to link directly to this book on Copyright Clearance Center's website.

Table of Contents:


Impaired Endothelial Function

Inflammatory Pathways Promote Atherosclerosis

The Composition of the Atherosclerotic Plaque


Therapeutic Approaches

Treatment of the Established Risk Factors



      Cardiology Research and Clinical Developments
   Binding: Softcover
   Pub. Date: 2009
   ISBN: 978-1-60692-677-2
   Status: AV
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Atherosclerosis: Understanding Pathogenesis and Challenge for Treatment